Literature DB >> 23384889

Altered serum miRNA profiles during acute rejection after heart transplantation: potential for non-invasive allograft surveillance.

Ihdina Sukma Dewi, Kristina Torngren, Olof Gidlöf, Björn Kornhall, Jenny Ohman.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23384889     DOI： 10.1016/j.healun.2012.12.007

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  12 in total

Review 1.  Novel Biomarker Approaches for Managing Patients With Cardiac Transplantation.

Authors:  Peter J Kennel; P Christian Schulze
Journal:  Curr Heart Fail Rep       Date:  2015-10

2.  MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation.

Authors:  Zhongping Xu; Sabarinathan Ramachandran; Muthukumar Gunasekaran; Fangyu Zhou; Elbert Trulock; Daniel Kreisel; Ramsey Hachem; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2015-03-27       Impact factor: 10.247

3.  Circulating microRNAs in cellular and antibody-mediated heart transplant rejection.

Authors:  Palak Shah; Sean Agbor-Enoh; Pramita Bagchi; Christopher R deFilippi; Angela Mercado; Gouqing Diao; Dave Jp Morales; Keyur B Shah; Samer S Najjar; Erika Feller; Steven Hsu; Maria E Rodrigo; Sabra C Lewsey; Moon Kyoo Jang; Charles Marboe; Gerald J Berry; Kiran K Khush; Hannah A Valantine
Journal:  J Heart Lung Transplant       Date:  2022-06-28       Impact factor: 13.569

4.  Role of Circulating MicroRNAs in the Immunopathogenesis of Rejection After Pediatric Lung Transplantation.

Authors:  Zhongping Xu; Wei Yang; Nancy Steward; Stuart C Sweet; Lara Danziger-Isakov; Peter S Heeger; Thalachallour Mohanakumar
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

Review 5.  Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease.

Authors:  Albert Busch; Suzanne M Eken; Lars Maegdefessel
Journal:  Ann Transl Med       Date:  2016-06

Review 6.  Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers.

Authors:  Perry V Halushka; Andrew J Goodwin; Marc K Halushka
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

Review 7.  MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential.

Authors:  Palak Shah; Michael R Bristow; J David Port
Journal:  Curr Heart Fail Rep       Date:  2017-12

8.  Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation.

Authors:  Ihdina Sukma Dewi; Zsuzsanna Hollander; Karen K Lam; Janet-Wilson McManus; Scott J Tebbutt; Raymond T Ng; Paul A Keown; Robert W McMaster; Bruce M McManus; Olof Gidlöf; Jenny Öhman
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 9.  The Potential of MicroRNAs as Novel Biomarkers for Transplant Rejection.

Authors:  Matthias Hamdorf; Satoru Kawakita; Matthew Everly
Journal:  J Immunol Res       Date:  2017-01-16       Impact factor: 4.818

10.  Biomarkers to Assess Right Heart Pressures in Recipients of a Heart Transplant: A Proof-of-Concept Study.

Authors:  Qi-Fang Huang; Sander Trenson; Zhen-Yu Zhang; Jan Van Keer; Lucas N L Van Aelst; Wen-Yi Yang; Esther Nkuipou-Kenfack; Lutgarde Thijs; Fang-Fei Wei; Blerim Mujaj; Agnieszka Ciarka; Walter Droogné; Johan Vanhaecke; Stefan Janssens; Johan Van Cleemput; Harald Mischak; Jan A Staessen
Journal:  Transplant Direct       Date:  2018-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.